Market Research Logo

Dermatology Drugs Market Global Report 2017 Including: Antibacterial, Anti-Fungal, Anti-ViralCovering: Galderma (Nestle Skin Health), Johnson & Johnson, AbbVie, GlaxosmithKline, and Pfizer

Dermatology Drugs Market Global Report 2017 Including: Antibacterial, Anti-Fungal, Anti-ViralCovering: Galderma (Nestle Skin Health), Johnson & Johnson, AbbVie, GlaxosmithKline, and Pfizer

The market has witnessed multiple strategic initiatives in the recent years. Top companies in the dermatology drugs market strategically acquired start-ups and mid-sized companies to broaden products and services.

The Dermatology Drugs Market Global Report provides strategists, marketers and senior management with the critical information they need to assess the global dermatology drugs sector.

Reasons to Purchase

  • Outperform competitors using accurate up to date demand-side dynamics information.
  • Identify growth segments for investment.
  • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
  • Create regional and country strategies on the basis of local data and analysis.
  • Stay abreast of the latest customer and market research findings
  • Benchmark performance against key competitors.
  • Develop strategies based on likely future developments.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Gain a global perspective on the development of the market.
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Description:

Where is the largest and fastest growing market for the dermatology drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The dermatology drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider pharmaceutical drugs market, and compares it with other markets.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
  • The dermatology drugs market section of the report gives context. It compares the dermatology drugs market with other segments of the pharmaceutical drugs market by size and growth, historic and forecast. It analyses Expenditure Per Capita, The Dermatology Drugs Indicators Comparison.
  • The industry metrics section looks at critical drivers including patient numbers (epidemiology) hospital beds and specialist physicians while the macro-economic section looks at the market in relation to the overall economy.
Scope

Markets Covered: Antibacterial, Anti-Fungal, Anti-Viral

Companies Mentioned: Galderma (Nestle Skin Health), Johnson & Johnson, AbbVie, GlaxosmithKline, and Pfizer

Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia.

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP, Expenditure Per Capita, The Dermatology Drugs Indicators Comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.


1. Dermatology Drugs Market Characteristics
2. Dermatology Drugs Market Size And Growth
2.1. Historic Market Growth
2.1.1. Drivers Of The Market
2.1.2. Restraints On The Market
2.2. Forecast Market Growth
2.2.1. Drivers Of The Market
2.2.2. Restraints On The Market
3. Pestle Analysis
3.1. Political
3.2. Economic
3.3. Social
3.4. Technological
3.5. Legal
3.6. Environmental
4. Dermatology Drugs Market Customer Information
5. Dermatology Drugs Market Segmentation
5.1. Global Dermatology Drugs Market, 2016, By Segment
Antibacterial
Anti-Fungal
Anti-Viral
5.2. Global Dermatology Drugs Market, 2012 - 2020, Historic And Forecast, By Segment
5.3 Global Dermatology Drugs Market Trends And Strategies
6. Dermatology Drugs Market Regional And Country Analysis
6.1. Global Dermatology Drugs Market, 2016, By Region
6.2. Global Dermatology Drugs Market, 2012 - 2020, Historic And Forecast, By Region
6.3. Dermatology Drugs Market, 2016, By Country
6.4. Dermatology Drugs Market, 2012 - 2020, Historic And Forecast, By Country
6.5. Global Pharmaceutical Market Segments, 2016, By Region
6.6. Global Pharmaceutical Drugs Market Segments, 2016, By Region
6.7. Global Pharmaceutical Market Segments, 2016, By Country
6.8. Global Pharmaceutical Drugs Market Segments, 2016, By Country
7. Global Dermatology Drugs Market Comparison With Macro Economic Factors
7.1. Dermatology Drugs Market Size, Percentage Of GDP, Global
7.2. Per Capita Average Dermatology Drugs Expenditure, Global
8. Dermatology Drugs Market Comparison With Macro Economic Factors Across Countries
8.1. Dermatology Drugs Market Size, Percentage Of GDP, By Country
8.2. Per Capita Average Dermatology Drugs Expenditure, By Country
9. Dermatology Drugs Market Comparison With Industry Metrics
9.1. Global Number Of Pharmacists, 2016, By Country
9.2. Global Dermatology Drugs Market Revenue Versus Number Of Pharmacists, 2016, By Country
9.3. Global Number Of Pharma Enterprises, 2016, By Country
9.4. Global Dermatology Drugs Market Revenue Versus Number Of Pharma Enterprises, 2016, By Country
9.5. Global Average Spending On R&D/Product Development, 2016, By Country
9.6. Global Dermatology Drugs Market Revenue Versus Average Spending On R&D/Product Development, 2016, By Country
9.7. Global Generic & Branded Sales Proportion By Country (Value), 2016, By Country
9.8. Global Dermatology Drugs Market Revenue Versus Generic & Branded Sales Proportion By Country (Value), 2016, By Country
9.9. Prevalent Cases Of Dermatitis, 2014, By Country
10. Asia-Pacific Dermatology Drugs Market
10.1.1. Asia-Pacific Dermatology Drugs Market Overview
10.1.2. Asia-Pacific Dermatology Drugs Historic Market, 2012 - 2016
10.1.3. Asia-Pacific Dermatology Drugs Forecast Market, 2016 - 2020
10.1.4. Asia-Pacific Dermatology Drugs Market, 2016, By Segment
Antibacterial
Anti-Fungal
Anti-Viral
10.2. Asia-Pacific Dermatology Drugs Market: Country Analysis
10.3. China Dermatology Drugs Market
10.3.1. China Dermatology Drugs Market Overview
10.3.2. China Dermatology Drugs Historic Market, 2012 - 2016
10.3.3. China Dermatology Drugs Forecast Market, 2016 - 2020
10.3.4. China Dermatology Drugs Market, 2016, By Segment
Antibacterial
Anti-Fungal
Anti-Viral
10.3.5. China Dermatology Drugs Percentage Of GDP, 2012 - 2020
10.3.6. China Per Capita Average Dermatology Drugs Expenditure, 2012 - 2020
10.4. India Dermatology Drugs Market
10.4.1. India Dermatology Drugs Market Overview
10.4.2. India Dermatology Drugs Historic Market, 2012 - 2016
10.4.3. India Dermatology Drugs Forecast Market, 2016 - 2020
10.4.4. India Dermatology Drugs Market, 2016, By Segment
Antibacterial
Anti-Fungal
Anti-Viral
10.4.5. India Dermatology Drugs Percentage Of GDP, 2012 - 2020
10.4.6. India Per Capita Average Dermatology Drugs Expenditure, 2012 - 2020
10.5. Japan Dermatology Drugs Market
10.5.1. Japan Dermatology Drugs Market Overview
10.5.2. Japan Dermatology Drugs Historic Market, 2012 - 2016
10.5.3. Japan Dermatology Drugs Forecast Market, 2016 - 2020
10.5.4. Japan Dermatology Drugs Market, 2016, By Segment
Antibacterial
Anti-Fungal
Anti-Viral
10.5.5. Japan Dermatology Drugs Percentage Of GDP, 2012 - 2020
10.5.6. Japan Per Capita Average Dermatology Drugs Expenditure, 2012 - 2020
10.6. Australia Dermatology Drugs Market
10.6.1. Australia Dermatology Drugs Historic Market, 2012 - 2016
10.6.2. Australia Dermatology Drugs Forecast Market, 2016 - 2020
10.6.3. Australia Dermatology Drugs Market, 2016, By Segment
Antibacterial
Anti-Fungal
Anti-Viral
10.6.4. Australia Dermatology Drugs Percentage Of GDP, 2012 - 2020
10.6.5. Australia Per Capita Average Dermatology Drugs Expenditure, 2012 - 2020
11. Western Europe Dermatology Drugs Market
11.1.1. Western Europe Dermatology Drugs Market Overview
11.1.2. Western Europe Dermatology Drugs Historic Market, 2012 - 2016
11.1.3. Western Europe Dermatology Drugs Forecast Market, 2016 - 2020
11.1.4. Western Europe Dermatology Drugs Market, 2016, By Segment
Antibacterial
Anti-Fungal
Anti-Viral
11.2. Western Europe Dermatology Drugs Market: Country Analysis
11.3. UK Dermatology Drugs Market
11.3.1. UK Dermatology Drugs Market Overview
11.3.2. UK Dermatology Drugs Historic Market, 2012 - 2016
11.3.3. UK Dermatology Drugs Forecast Market, 2016 - 2020
11.3.4. UK Dermatology Drugs Market, 2016, By Segment
Antibacterial
Anti-Fungal
Anti-Viral
11.3.5. UK Dermatology Drugs Percentage Of GDP, 2012 - 2020
11.3.6. UK Per Capita Average Dermatology Drugs Expenditure, 2012 - 2020
11.4. Germany Dermatology Drugs Market
11.4.1. Germany Dermatology Drugs Historic Market, 2012 - 2016
11.4.2. Germany Dermatology Drugs Forecast Market, 2016 - 2020
11.4.3. Germany Dermatology Drugs Market, 2016, By Segment
Antibacterial
Anti-Fungal
Anti-Viral
11.4.4 Germany Dermatology Drugs Percentage Of GDP, 2012 - 2020
11.4.5 Germany Per Capita Average Dermatology Drugs Expenditure, 2012 - 2020
11.5 France Dermatology Drugs Market
11.5.1 France Dermatology Drugs Historic Market, 2012 - 2016
11.5.2 France Dermatology Drugs Forecast Market, 2016 - 2020
11.5.3 France Dermatology Drugs Market, 2016, By Segment
Antibacterial
Anti-Fungal
Anti-Viral
11.5.4 France Dermatology Drugs Percentage Of GDP, 2012 - 2020
11.5.5 France Per Capita Average Dermatology Drugs Expenditure, 2012 - 2020
11.6. Italy Dermatology Drugs Market
11.6.1. Italy Dermatology Drugs Historic Market, 2012 - 2016
11.6.2. Italy Dermatology Drugs Forecast Market, 2016 - 2020
11.6.3. Italy Dermatology Drugs Market, 2016, By Segment
Antibacterial
Anti-Fungal
Anti-Viral
11.6.4. Italy Dermatology Drugs Percentage Of GDP, 2012 - 2020
11.6.5. Italy Per Capita Average Dermatology Drugs Expenditure, 2012 - 2020
11.7. Spain Dermatology Drugs Market
11.7.1. Spain Dermatology Drugs Historic Market, 2012 - 2016
11.7.2. Spain Dermatology Drugs Forecast Market, 2016 - 2020
11.7.3. Spain Dermatology Drugs Market, 2016, By Segment
Antibacterial
Anti-Fungal
Anti-Viral
11.7.4. Spain Dermatology Drugs Percentage Of GDP, 2012 - 2020
11.7.5. Spain Per Capita Average Dermatology Drugs Expenditure, 2012 - 2020
12. Eastern Europe Dermatology Drugs Market
12.1.1. Eastern Europe Dermatology Drugs Market Overview
12.1.2. Eastern Europe Dermatology Drugs Historic Market, 2012 - 2016
12.1.3. Eastern Europe Dermatology Drugs Forecast Market, 2016 - 2020
12.1.4 Eastern Europe Dermatology Drugs Market, 2016, By Segment
Antibacterial
Anti-Fungal
Anti-Viral
12.2. Eastern Europe Dermatology Drugs Market: Country Analysis
12.3. Russia Dermatology Drugs Market
12.3.1. Russia Dermatology Drugs Historic Market, 2012 - 2016
12.3.2. Russia Dermatology Drugs Forecast Market, 2016 - 2020
12.3.3. Russia Dermatology Drugs Market, 2016, By Segment
Antibacterial
Anti-Fungal
Anti-Viral
12.3.4. Russia Dermatology Drugs Percentage Of GDP, 2012 - 2020
12.3.5. Russia Per Capita Average Dermatology Drugs Expenditure, 2012 - 2020
13. North America Dermatology Drugs Market
13.1.1. North America Dermatology Drugs Market Overview
13.1.2. North America Dermatology Drugs Historic Market, 2012 - 2016
13.1.3. North America Dermatology Drugs Forecast Market, 2016 - 2020
13.1.4. North America Dermatology Drugs Market, 2016, By Segment
Antibacterial
Anti-Fungal
Anti-Viral
13.2. North America Dermatology Drugs Market: Country Analysis
13.3. USA Dermatology Drugs Market
13.3.1. USA Dermatology Drugs Historic Market, 2012 - 2016
13.3.1. USA Dermatology Drugs Historic Market, 2012 - 2016
13.3.2. USA Dermatology Drugs Forecast Market, 2016 - 2020
13.3.3 USA Dermatology Drugs Market, 2016, By Segment
Antibacterial
Anti-Fungal
Anti-Viral
13.3.4. USA Dermatology Drugs Percentage Of GDP, 2012 - 2020
13.3.5. USA Per Capita Average Dermatology Drugs Expenditure, 2012 - 2020
14. South America Dermatology Drugs Market
14.1.1. South America Dermatology Drugs Market Overview
14.1.2. South America Dermatology Drugs Historic Market, 2012 - 2016
14.1.3. South America Dermatology Drugs Forecast Market, 2016 - 2020
14.1.4. South America Dermatology Drugs Market, 2016, By Segment
Antibacterial
Anti-Fungal
Anti-Viral
14.2. South America Dermatology Drugs Market: Country Analysis
14.3. Brazil Dermatology Drugs Market
14.3.1. Brazil Dermatology Drugs Historic Market, 2012 - 2016
14.3.2. Brazil Dermatology Drugs Forecast Market, 2016 - 2020
14.3.3. Brazil Dermatology Drugs Market, 2016, By Segment
Antibacterial
Anti-Fungal
Anti-Viral
14.3.4. Brazil Dermatology Drugs Percentage Of GDP, 2012 - 2020
14.3.5. Brazil Per Capita Average Dermatology Drugs Expenditure, 2012 - 2020
15. Middle East Dermatology Drugs Market
15.1.1. Middle East Dermatology Drugs Market Overview
15.1.2. Middle East Dermatology Drugs Historic Market, 2012 - 2016
15.1.3. Middle East Dermatology Drugs Forecast Market, 2016 - 2020
15.1.4. Middle East Dermatology Drugs Market, 2016, By Segment
Antibacterial
Anti-Fungal
Anti-Viral
16. Africa Dermatology Drugs Market
16.1.1. Africa Dermatology Drugs Market Overview
16.1.2. Africa Dermatology Drugs Historic Market, 2012 - 2016
16.1.3. Africa Dermatology Drugs Forecast Market, 2016 - 2020
16.1.4. Africa Dermatology Drugs Market, 2016, By Segment
Antibacterial
Anti-Fungal
Anti-Viral
17. Dermatology Drugs Market Competitive Landscape
17.1. Company Profiles
17.2. Galderma (Nestle Skin Health)
17.2.1. Overview
17.2.2. Products And Services
17.2.3. Strategy
17.2.4. Financial Performance
17.3. Johnson & Johnson
17.3.1. Overview
17.3.2. Products And Services
17.3.3. Strategy
17.3.4. Financial Performance
17.4. Abbvie
17.4.1. Overview
17.4.2. Products And Services
17.4.3. Strategy
17.4.4. Financial Performance
17.5. Glaxosmithkline
17.5.1. Overview
17.5.2. Products And Services
17.5.3. Strategy
17.5.4. Financial Performance
17.6. Pfizer
17.6.1. Overview
17.6.2. Products And Services
17.6.3. Strategy
17.6.4. Financial Performance
18. Key Mergers And Acquisitions In The Dermatology Drugs Market
19. Market Background: Pharmaceutical Drugs Market
19.1.1. Pharmaceutical Drugs Market Characteristics
19.1.2. Pharmaceutical Drugs Market Historic Growth
19.1.2.1. Drivers Of The Market
19.1.2.2. Restraints Of The Market
19.1.3. Pharmaceutical Drugs Market Forecast Growth
19.1.3.1. Drivers Of The Market
19.1.3.2. Restraints Of The Market
19.1.4. Pharmaceutical Drugs Trends And Strategies
19.2. Pharmaceutical Drugs Market Regional And Country Analysis
19.2.1. Global Pharmaceutical Drugs Market, 2016, By Region
19.2.2. Global Pharmaceutical Drugs Market, 2012 - 2020, Historic And Forecast, By Region
19.2.3. Pharmaceutical Drugs Market, 2016, By Country
19.2.4. Pharmaceutical Drugs Market, 2012 - 2020, Historic And Forecast, By Country
19.2.5. Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Segment
19.2.6. Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Country And Segment
19.3. Global Pharmaceutical Drugs Market Comparison With Macro Economic Factors
19.3.2. Per Capita Average Pharmaceutical Drugs Expenditure, Global
19.4. Pharmaceutical Drugs Market Comparison With Macro Economic Factors Across Countries
19.4.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, By Country
19.4.2. Per Capita Average Pharmaceutical Drugs Expenditure, By Country
19.5. Key Mergers And Acquisitions In The Pharmaceutical Drugs Market
20. Pharmaceuticals Industry Financial Margins
21. Appendix
21.1. NAICS Definitions Of Industry Covered In This Report
21.2. Abbreviations
21.3. Currencies
21.4. Research Inquiries
21.5. The Business Research Company
21.6. Copyright And Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report